All Stories

  1. Sestrin 2 levels are associated with emphysematous phenotype of COPD

    Article • PLoS ONE, August 2022, PLOS

    Professor Petros A Bakakos

  2. Evaluation of asthma control and quality of life after 6 months of treatment with FDC Budesonide/Formoterol-BOREAS study

    Article • September 2019, European Respiratory Society (ERS)

    Professor Petros A Bakakos

  3. Inflammatory profile in optimally treated patients with adult versus early-onset asthma

    Article • Postgraduate Medicine, March 2019, Taylor & Francis

    Nickolaos Koulouris, Professor Petros A Bakakos, Anastasia Papaporfyriou

  4. Experimental and investigational phosphodiesterase inhibitors in development for asthma

    Article • Expert Opinion on Investigational Drugs, January 2019, Taylor & Francis

    Professor Petros A Bakakos, ANGELIKI DETTA

  5. Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes

    Article • Allergy, May 2017, Wiley

    Professor Petros A Bakakos, Georgios Papatheodorou

  6. Sputum interleukin-13 as a biomarker for the evaluation of asthma control

    Article • Clinical & Experimental Allergy, May 2016, Wiley

    Professor Petros A Bakakos, Anastasia Papaporfyriou

  7. Vascular Biomarkers in Asthma and COPD

    Article • Current Topics in Medicinal Chemistry, March 2016, Bentham Science Publishers

    Professor Petros A Bakakos

  8. Sputum and BAL Clara cell secretory protein and surfactant protein D levels in asthma

    Article • Allergy, March 2015, Wiley

    Professor Petros A Bakakos, Anastasia Papaporfyriou

  9. Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects

    Article • January 2015, Springer Science + Business Media

    Professor Petros A Bakakos

  10. Increased Levels of Osteopontin in Sputum Supernatant in Patients With COPD

    Article • CHEST Journal, October 2014, Elsevier

    Professor Petros A Bakakos, Anastasia Papaporfyriou

  11. The Relationship Between the Adherence to Treatment and the Psychological Profile of Patients With Chronic Obstructive Pulmonary Disease

    Article • CHEST Journal, March 2014, Elsevier

    Professor Petros A Bakakos

  12. Biomarkers in Chronic Obstructive Pulmonary Disease (COPD): Current Concerns and Future Prospects

    Article • January 2014, Springer Science + Business Media

    Professor Petros A Bakakos

  13. Serum Angiopoietin-2 and CRP Levels During COPD Exacerbations

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, October 2013, Taylor & Francis

    Professor Petros A Bakakos

  14. Biomarkers in COPD: Is Mortality the Holy Grail?

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, September 2013, Taylor & Francis

    Professor Petros A Bakakos

  15. Vascular endothelial growth factor and cysteinyl leukotrienes in sputum supernatant of patients with asthma

    Article • Respiratory Medicine, September 2013, Elsevier

    Professor Petros A Bakakos

  16. Noninvasive evaluation of airway inflammation in patients with severe asthma

    Article • Annals of Allergy Asthma & Immunology, May 2013, Elsevier

    Professor Petros A Bakakos, Anastasia Papaporfyriou

  17. Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment

    Article • Sleep And Breathing, February 2013, Springer Science + Business Media

    Professor Petros A Bakakos

  18. Editorial (Hot Topic: COPD Management Beyond Bronchodilation: Current Targets and Future Prospects)

    Article • Current Drug Targets, January 2013, Bentham Science Publishers

    Professor Petros A Bakakos

  19. Increased levels of osteopontin in sputum supernatant of smoking asthmatics

    Article • Cytokine, January 2013, Elsevier

    Professor Petros A Bakakos

  20. Systemic Biomarkers in the Evaluation and Management of COPD Patients: Are We Getting Closer to Clinical Application?

    Article • Current Drug Targets, January 2013, Bentham Science Publishers

    Professor Petros A Bakakos

  21. Levels of angiopoietins 1 and 2 in induced sputum supernatant in patients with COPD

    Article • Cytokine, June 2012, Elsevier

    Professor Petros A Bakakos

  22. Increased levels of angiopoietins 1 and 2 in sputum supernatant in severe refractory asthma

    Article • Allergy, January 2012, Wiley

    Professor Petros A Bakakos

  23. The Inflammatory Effector Cell Pattern in Asthma and Chronic Obstructive Pulmonary Disease – What Is It Good for?

    Article • Respiration, January 2012, Karger Publishers

    Professor Petros A Bakakos

  24. Associations between BODE Index and Systemic Inflammatory Biomarkers in COPD

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, December 2011, Taylor & Francis

    Professor Petros A Bakakos

  25. VEGF and IL-18 in induced sputum of lung cancer patients

    Article • Cytokine, June 2011, Elsevier

    Dr Nikoletta Rovina, Professor Petros A Bakakos

  26. Editorial [Hot Topic: Non-Invasive Assessment of Asthmatic Inflammation: From Bench to Bedside (Guest Editors: S. Loukides, K. Kostikas and P. Bakakos)]

    Article • Current Medicinal Chemistry, April 2011, Bentham Science Publishers

    Professor Petros A Bakakos

  27. Induced Sputum in Asthma: From Bench to Bedside

    Article • Current Medicinal Chemistry, April 2011, Bentham Science Publishers

    Professor Petros A Bakakos

  28. Oxidative Stress in Patients with COPD

    Article • Current Drug Targets, April 2011, Bentham Science Publishers

    Professor Petros A Bakakos

  29. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease

    Article • European Journal of Internal Medicine, February 2011, Elsevier

    Professor Petros A Bakakos

  30. The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

    Article • Cancer Management and Research, November 2010, Taylor & Francis

    Dr Fotios Vlastos, Professor Petros A Bakakos

  31. The disparity of health facilities in an urban area discourages proposed treatment application in inoperable lung cancer patients

    Article • Cancer Management and Research, November 2010, Dove Medical Press

    Professor Petros A Bakakos

  32. Exhaled breath condensate: hydrogen peroxide

    Article • September 2010, European Respiratory Society (ERS)

    Professor Petros A Bakakos

  33. Increased levels of osteopontin in sputum supernatant in severe refractory asthma

    Article • Thorax, August 2010, BMJ

    Professor Petros A Bakakos

  34. Exhaled Nitric Oxide and Exhaled Breath Condensate pH in Severe Refractory Asthma

    Article • CHEST Journal, July 2010, Elsevier

    Professor Petros A Bakakos

  35. COMPLIANCE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TO A PULMONARY REHABILITATION PROGRAM: ITS IMPACT ON THE OUTCOMES AND ITS PROGNOSTICATION

    Article • CHEST Journal, October 2009, Elsevier

    Professor Petros A Bakakos

  36. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator-associated pneumonia

    Article • European Respiratory Journal, August 2009, European Respiratory Society (ERS)

    Professor Petros A Bakakos

  37. Biomarkers Obtained by Non-Invasive Methods in Patients with COPD: Where do we Stand, what do we Expect?

    Article • Current Medicinal Chemistry, August 2009, Bentham Science Publishers

    Professor Petros A Bakakos

  38. Noninvasive evaluation of airway inflammation in asthmatic patients who smoke: implications for application in clinical practice

    Article • Annals of Allergy Asthma & Immunology, September 2008, Elsevier

    Professor Petros A Bakakos

  39. Carcinoembryonic antigen, neuron‐specific enolase and cytokeratin fragment 19 (CYFRA 21‐1) levels in induced sputum of lung cancer patients

    Article • Scandinavian Journal of Clinical and Laboratory Investigation, January 2008, Taylor & Francis

    Professor Petros A Bakakos

  40. P1746 Serum procalcitonin and organ failure in critically ill patients with sepsis

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Petros A Bakakos

  41. P1747 The impact of insulin therapy on infiammatory markers in critically ill patients with sepsis

    Article • International Journal of Antimicrobial Agents, March 2007, Elsevier

    Professor Petros A Bakakos

  42. Tuberculous Effusion: ADA Activity Correlates with CD4+ Cell Numbers in the Fluid and the Pleura

    Article • Respiration, January 2005, Karger Publishers

    Professor Petros A Bakakos

  43. Chylothorax and Pseudochylothorax

    Article • February 2004, Taylor & Francis

    Professor Petros A Bakakos

  44. TCR usage and cytokine expression in peripheral blood and BAL T cells

    Article • Clinical & Experimental Immunology, May 2002, Wiley

    Professor Petros A Bakakos

  45. Plasma and Urine Elastase Alpha-1-Proteinase Inhibitor Levels in Neonatal Urinary Tract Infection

    Article • Neonatology, January 2002, Karger Publishers

    Professor Petros A Bakakos

  46. Regulation of allergy and asthma by T-cell Vbeta family subsets

    Article • Clinical & Experimental Allergy, December 1998, Wiley

    Professor Petros A Bakakos

  47. Intracellular Cytokine Staining for Analysis by Flow Cytometry

    Article • Springer Science + Business Media

    Professor Petros A Bakakos